By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Boston Therapeutics, Inc. 

1750 Elm Street
Suite 103
Manchester  New Hampshire  03104  U.S.A.
Phone: 603-935-9799 Fax: 603-685-4784



Company News
Boston Therapeutics Reports Data From The POC Asia Trial At The American Diabetes Association’s 77th Scientific Sessions 6/19/2017 7:14:04 AM
Boston Therapeutics Secures $1 Million Financing For The First Phase Multi-Centre International Ph II-III Trial 4/27/2017 1:50:40 PM
Boston Therapeutics Business Update 2/7/2017 7:50:34 AM
Boston Therapeutics Announces Innovation Grant 10/14/2016 7:11:23 AM
Boston Therapeutics Reports Positive Topline Data From Proof Of Concept Asia Trial 10/7/2016 10:56:58 AM
Boston Therapeutics Completes Private Offering, Appoints New CEO 10/4/2016 12:48:15 PM
Boston Therapeutics' sugardown(R) In Clinical Trials Reduces Glucose, Fructose And Insulin 12/29/2015 9:00:47 AM
Boston Therapeutics Reports Third Quarter Results And Provides Corporate Update 11/23/2015 12:40:31 PM
Boston Therapeutics, Inc. Completes Enrollment For BTI-320 Clinical Trial 10/7/2015 1:20:38 PM
Boston Therapeutics, Inc. Pays Off Convertible Promissory Notes 10/1/2015 1:03:10 PM